Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44394 clinical trials with a EudraCT protocol, of which 7406 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,394)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,394 result(s) found. Displaying page 994 of 2,220.

EudraCT Number: 2008-001396-30

Sponsor Protocol Number: A7881010

Start Date*: 2008-09-26

Sponsor Name:Pfizer Ltd, Ramsgate Road, Sandwich, Kent, UK

Full Title: A PHASE 2A, DOUBLE BLIND (3RD PARTY OPEN), 4 WAY CROSS-OVER, PLACEBO CONTROLLED STUDY TO INVESTIGATE THE PHARMACOKINETICS, SAFETY, TOLERATION AND EFFICACY OF SINGLE INHALED DOSES OF PF-00610355 IN ...

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10009033	Chronic obstructive pulmonary disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2008-002096-27

Sponsor Protocol Number: CFTY720D2309

Start Date*: 2008-09-10

Sponsor Name:Novartis Pharma Services AG

Full Title: A 24-month double-blind, randomized, multicenter, placebocontrolled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...

Medical condition: Relapsing-remitting multiple sclerosis.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13.1	10029205 - Nervous system disorders	10063399	Relapsing-remitting multiple sclerosis	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: PL (Completed) AT (Completed) LT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2008-001416-20

Sponsor Protocol Number: DSC/07/2357/29

Start Date*: 2009-05-19

Sponsor Name:ITALFARMACO

Full Title: Phase II High Pulse Dose Clinical Trial of Orally Administered ITF 2357 In Patients with Relapsed/Refractory Multiple Myeloma

Medical condition: Patients with Relapsed/Refractory Multiple Myeloma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10028229	Multiple myelomas	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2008-001835-36

Sponsor Protocol Number: 68923

Start Date*: 2008-07-09

Sponsor Name:Gedeon Richter Plc.

Full Title: Single center, exploratoric, open-label study to investigate the add-on effect of vinpocetin to the haemorheological effect of 100 mg acetyl-salicylicum in patients with chronic cerebrovascular dis...

Medical condition: Aspirin resistance in patients with chronic cerebrovascular disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045652	Unspecified cerebrovascular disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: View results

EudraCT Number: 2008-001413-14

Sponsor Protocol Number: 205.416

Start Date*: 2008-08-20

Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG

Full Title: A Phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat ® inhaler (5 μg/day) over 48 ...

Medical condition: Patients with severe persistent asthma who are still symptomatic despite being treated with high-dose inhaled corticosteroids and long-acting beta2-agonists. Additional asthma treatments are allowe...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10049106	Asthma chronic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) NL (Completed) IT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2008-000511-16

Sponsor Protocol Number: HTA05/503/04

Start Date*: 2008-08-22

Sponsor Name:Keele University [...]

Full Title: Management of Asthma in School age Children On Therapy

Medical condition: Chronic asthma (paediatric population)

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10049106	Asthma chronic	LLT
	9.1		10049868	Asthma exacerbation prophylaxis	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2007-000319-27

Sponsor Protocol Number: ALT-711-0527

Start Date*: 2007-07-02

Sponsor Name:Alteon, Inc.

Full Title: A Double-blind, Placebo-Controlled, Randomized Trial Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients with Chronic Heart Failure

Medical condition: Heart Failure

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10008908	Chronic heart failure	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-000895-25	Sponsor Protocol Number: V87P11	Start Date*: 2008-10-18
Sponsor Name:Novartis Vaccines and Diagnostics GmbH & Co. KG
Full Title: A Phase II, Open-label, multi center Study to Evaluate the Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects
Medical condition: The present study is therefore designed to evaluate the immunogenicity, safety and tolerability of two doses of FLUAD-H5N1 vaccine containing A/H5N1/turkey/Turkey/05 administered 3 weeks apart in n...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: View results

EudraCT Number: 2008-003285-26

Sponsor Protocol Number: ASTA

Start Date*: Information not available in EudraCT

Sponsor Name:Universität Mainz, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und -psychotherapie

Full Title: Effect of methylphenidate formulation on ADHD-patients' adherence to medical treatment. A comparison of Medikinet retard® (ER) once daily and Medikinet® (IR) twice daily in children and adolescents...

Medical condition: Effect of methylphenidate formulation on ADHD-patients adherence to treatment

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10064104	ADHD	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2007-006648-23

Sponsor Protocol Number: CIGE025A2437

Start Date*: 2008-11-12

Sponsor Name:Novartis Pharma Services AG

Full Title: An exploratory, randomized, double-blind, placebo controlled study to assess the efficacy of multiple doses of omalizumab in cystic fibrosis complicated with allergic bronchopulmonary aspergillosis

Medical condition: Patients with cystic fibrosis complicated by allergic bronchopulmonary aspergillosis.

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10011763	Cystic fibrosis lung	LLT
	9.1		10000244	ABPA	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) BE (Completed) NL (Prematurely Ended) GB (Prematurely Ended) IE (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2007-004609-85

Sponsor Protocol Number: UV2005/01

Start Date*: 2008-03-18

Sponsor Name:OM Pharma SA

Full Title: Multicentre, randomised, double-blind, placebo-controlled clinical study to assess the efficacy and safety of UroVaxom in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)

Medical condition: Chronic prostatitis and chronic pelvic pain syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10038604 - Reproductive system and breast disorders	10064189	Chronic pelvic pain syndrome	LLT
	14.1	10038604 - Reproductive system and breast disorders	10009109	Chronic prostatitis	LLT

Population Age: Adults

Gender: Male

Trial protocol: DE (Completed) AT (Completed) PT (Completed)

Trial results: View results

EudraCT Number: 2008-002117-46

Sponsor Protocol Number: 08-BO-LSBE

Start Date*: 2008-07-22

Sponsor Name:Medizinische Klinik I, St. Josef-Hospital, Ruhr-Universität Bochum

Full Title: Veränderungen der endogenen Insulin- und Glukagonsekretion während einer basalen Insulin-Substitution

Medical condition: Diabetes mellitus Typ 2

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-001291-71	Sponsor Protocol Number: W005PS0208_1	Start Date*: 2008-07-23
Sponsor Name:University of Wuerzburg
Full Title: Electrophysiological correlates of putative endophenotypes of attention-deficit / hyperactivity disorder (ADHD)
Medical condition: Attention-deficit hyperactivity disorder (ADHD)
Disease:
Population Age: Children, Adolescents, Under 18, Adults		Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-002030-30

Sponsor Protocol Number: AR_HSG_01-2008

Start Date*: 2008-04-24

Sponsor Name:A.O. SAN GERARDO DI MONZA

Full Title: Impact of intraperitonael nebulization of local anesthetic on hypothermia and postoperative pain associated with laparoscopic surgery

Medical condition: Intra and post operatorive period

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10038604	Reproductive system and breast disorders	SOC

Population Age: Adults

Gender: Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2008-001149-24	Sponsor Protocol Number: P/2008/70	Start Date*: 2008-06-04
Sponsor Name:Centre Hospitalier Universitaire de Besançon
Full Title: Fibrose hépatique sous Méthotrexate : Etude de la fréquence et facteurs associés au cours de trois affections distinctes (Psoriasis, Polyarthrite rhumatoïde et Maladie de Crohn)
Medical condition: 3 conditions médicales étudiées: Psoriasis Maladie de Crohn Polyarthrite rhumatoïde
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-002246-33

Sponsor Protocol Number: HLS03/2008

Start Date*: 2008-06-18

Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)

Full Title: Local application of mitomicin C for the treatment of stricturing Crohns disease: a phase III, single-center, randomized clinical trial

Medical condition: Stricturing Crohns disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10017947	Gastrointestinal disorders	SOC

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-003169-19

Sponsor Protocol Number: CYC-201

Start Date*: 2009-11-09

Sponsor Name:Sigmoid Pharma Ltd

Full Title: A Randomized, Double-blind, Placebo-controlled Study of a Controlled Release Minicapusle Formulation of Ciclosporin (CyCol™) in the Treatment of Ulcerative Colitis

Medical condition: Ulcerative colitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045365	Ulcerative colitis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Completed) GB (Completed)

Trial results: (No results available)

EudraCT Number: 2008-000105-11

Sponsor Protocol Number: ML21469

Start Date*: 2008-08-19

Sponsor Name:Roche Pharma AG

Full Title: Effectiveness after 4 and 24 weeks and safety of tocilizumab in patients with active RA

Medical condition: Rheumatoid Arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10039073	Rheumatoid arthritis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2007-005613-19

Sponsor Protocol Number: R-COMP 14

Start Date*: 2007-04-27

Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE S. SALVATORE

Full Title: R-COMP 14 in elderly patients with high grade non-Hodgkin lymphoma

Medical condition: Elderly patients with B non-Hodgkin lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10025320	Lymphomas non-Hodgkin's B-cell	HLGT

Population Age: Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2008-000349-68

Sponsor Protocol Number: B0451004

Start Date*: 2008-11-05

Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York NY10017

Full Title: A PHASE II PROSPECTIVE, RANDOMIZED, MULTI-CENTER, DIABETIC MACULAR EDEMA DOSE RANGING, COMPARATOR STUDY EVALUATING THE EFFICACY AND SAFETY OF PF-04523655 VERSUS LASER THERAPY (DEGAS)

Medical condition: Diabetic Macular Edema

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10057934	Diabetic macular edema	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) DE (Prematurely Ended)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Sun May 17 12:29:49 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA